Imunon, Inc. (IMNN) Free cash flow 2016–2025
Imunon, Inc. (IMNN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.2MFY2025 · since FY2016: -$18.4M → -$14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.2M | +24.9% |
| FY2024 | -$18.9M | +3.0% |
| FY2023 | -$19.5M | +16.7% |
| FY2022 | -$23.4M | -41.3% |
| FY2021 | -$16.5M | -5.7% |
| FY2020 | -$15.6M | +24.1% |
| FY2019 | -$20.6M | -187.0% |
| FY2018 | -$7.2M | +57.0% |
| FY2017 | -$16.7M | +9.5% |
| FY2016 | -$18.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice